merck glp 1 agonist Comparing Ozempic, Wegovy and Other GLP-1 Drugs GLP-1 Agonists Market Report 2025-2033,

Sheffield C

As use of these drugs is expected to expand to other health conditions, there is a pressing need for physical therapists to adapt their practices to support the long-term health goals of their patients and ensure optimal patient outcomes

This analysis examines publicly available formularies of plans available on the federally facilitated Affordable Care Act (ACA) Marketplace in 2024 to identify how utilization management tools are used for GLP-1 agonists

MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer

Data were collected from patient records where available and included in the analysis as exploratory outcomes